Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 185.10
+6.00 (3.35%)
Jun 18, 2026, 4:08 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 16.2 billion as of June 18, 2026. Its market cap has decreased by -8.93% in one year.
Market Cap
16.20B
Enterprise Value
12.60B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
185.10
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has decreased from 17.51B to 16.20B, a decrease of -7.53%. That is a compound annual growth rate of -6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 16.20B | -39.26% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 24.66B |
| InnoCare Pharma | 21.72B |
| Metis TechBio | 16.75B |
| Keymed Biosciences | 16.47B |
| Zai Lab | 15.74B |
| TenNor Therapeutics (Suzhou) | 13.30B |
| Ascentage Pharma Group International | 11.75B |
| TransThera Sciences (Nanjing) | 11.51B |